文献速递创伤与烧伤复苏、休克与脓毒症

接受大量输血的女性患者尽管存在生存获益仍较少接受全血

Female patients receiving massive transfusion are less likely to receive whole blood despite survival benefit.
PubMed 文献 · J Trauma Acute Care Surg · 2025-11-12
一句话结论创伤大量输血患者中女性接受全血的比例显著低于男性,但高比例全血与两性30天死亡率降低相关,仅绝经后女性亚组持续获益。

基于2020-2023年创伤质量改进项目数据库的回顾性研究,纳入33,811例接受大量输血(到达4小时内≥5单位血制品)的18-64岁成人创伤患者,其中女性占19.2%,29.6%接受了全血。校正混杂因素后,绝经前女性(aOR 0.403,95%CI 0.367-0.442)和绝经后女性(aOR 0.655,95%CI 0.531-0.808)接受全血的可能性均显著低于男性。高全血比例与男性(aOR 0.808,95%CI 0.725-0.901)和女性(aOR 0.776,95%CI 0.617-0.976)30天死亡率降低相关,但亚组分析中该效应仅见于绝经后女性(aOR 0.589,95%CI 0.384-0.903)。作者认为应解决输血实践中的性别差异并探究其根源。

要点

  • 在需大量输血的创伤患者中,仅29.6%接受了全血,女性绝经前(aOR 0.403)和绝经后(aOR 0.655)接受全血的可能性均显著低于男性。
  • 高全血比例与男性30天死亡率降低相关(aOR 0.808,95%CI 0.725-0.901),与女性总体也相关(aOR 0.776,95%CI 0.617-0.976)。
  • 亚组分析中,高全血比例的生存获益仅见于绝经后女性(aOR 0.589,95%CI 0.384-0.903),绝经前女性未显示持续获益。
  • 大量输血定义为到达后4小时内接受≥5单位血制品;全血比例按全血/含红细胞总单位计算,以非零全血比例的中位数分为低全血和高全血组。
  • 作者认为应解决输血实践中的性别差异,并探究差异根源以优化所有患者结局。

适用人群与场景

  • 2020-2023年创伤质量改进项目数据库中18至64岁成人创伤患者,接受大量输血(到达4小时内≥5单位血制品)。
  • 排除:转院患者、烧伤、1小时内死亡、接受任何血制品>100单位的患者。

诊断标准与关键阈值

  • 大量输血定义为到达后4小时内接受≥5单位血制品。
  • 全血比例=全血单位/含红细胞总单位;以非零全血比例的中位数将接受全血者分为低全血和高全血组,最终分为无全血、低全血和高全血三组。

研究设计与关键结果

  • 回顾性研究,纳入33,811例患者(女性19.2%),29.6%接受了全血。
  • 校正混杂因素后,绝经前女性接受全血的可能性低于男性(aOR 0.403,95%CI 0.367-0.442),绝经后女性也低于男性(aOR 0.655,95%CI 0.531-0.808)。
  • 混合效应回归分析显示,高全血比例与男性30天死亡率降低相关(aOR 0.808,95%CI 0.725-0.901),与女性也相关(aOR 0.776,95%CI 0.617-0.976)。
  • 亚组分析中,该效应仅见于绝经后女性(aOR 0.589,95%CI 0.384-0.903)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,证据等级:治疗/临床管理,Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,女性创伤患者在接受大量输血时接受全血的可能性低于男性,尽管存在生存获益,应解决输血实践中的性别差异并探究其根源。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Female trauma patients may be less likely to receive whole blood (WB) because of clinician concern regarding RhD alloimmunization and physiologic differences despite evidence supporting the safety of WB use in this population. We hypothesized that, in female patients requiring massive transfusion (MT), high proportions of WB are associated with decreased mortality but that females are less likely to receive WB than males.

METHODS: Adults aged 18 to 64 years from the 2020-2023 Trauma Quality Improvement Program database who received MT (≥5 blood units within 4 hours of arrival) were retrospectively reviewed. Transfers, burns, deaths within 1 hour, and patients who received >100 U of any blood product were excluded. The proportion of MT given as WB was calculated as WB ratio (WB/total red blood cell-containing units). The median of nonzero WB ratios was used to divide patients who received WB into two cohorts, ultimately creating three groups (no WB, low WB, and high WB). Mixed-effect logistic regressions were performed to assess the effect of sex on receiving WB and the effect of WB proportions on mortality.

RESULTS: Of 33,811 patients (19.2% female), 29.6% received WB. After controlling for confounders, both pre- and postmenopausal females were significantly less likely to receive WB than males (premenopausal: adjusted odds ratio [aOR], 0.403 [0.367-0.442]; postmenopausal: aOR, 0.655 [0.531-0.808]). On mixed-effect regression analysis, high WB ratios were associated with decreased 30-day mortality for both males (aOR, 0.808 [0.725-0.901]) and females (aOR, 0.776 [0.617-0.976]). On subanalysis, this effect persisted only for postmenopausal females (aOR, 0.589 [0.384-0.903]).

CONCLUSION: Female trauma patients are less likely than males to receive WB during MT despite a survival benefit. These results underscore the need to address sex-based differences in transfusion practices. The root of this disparity should be investigated to optimize outcomes for all patients.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Arcieri TR, Cobler-Lichter MD, Reyes AM, et al. Female patients receiving massive transfusion are less likely to receive whole blood despite survival benefit. J Trauma Acute Care Surg. 2025. PMID: 41649416. doi:10.1097/TA.0000000000004818

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。